Aptevo Therapeutics Inc. 10-Q, 10-Q/A, 10-QT, and 10-QT/A reports

Location
2401 4 Th Ave., Suite 1050, Seattle, WA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
11/7/2024, 08:33 AM
Form type Sec Links Description Filing date Reporting date
10-Q Report | Data 10-Q Nov 7, 2024 Sep 30, 2024
10-Q Report | Data 10-Q Aug 8, 2024 Jun 30, 2024
10-Q Report | Data 10-Q May 8, 2024 Mar 31, 2024
10-Q Report | Data 10-Q Nov 14, 2023 Sep 30, 2023
10-Q Report | Data 10-Q Aug 10, 2023 Jun 30, 2023
10-Q Report | Data 10-Q May 11, 2023 Mar 31, 2023
10-Q Report | Data 10-Q Nov 10, 2022 Sep 30, 2022
10-Q Report | Data 10-Q Aug 11, 2022 Jun 30, 2022
10-Q Report | Data 10-Q May 12, 2022 Mar 31, 2022
10-Q Report | Data 10-Q Nov 12, 2021 Sep 30, 2021
10-Q Report | Data 10-Q Aug 12, 2021 Jun 30, 2021
10-Q Report | Data 10-Q May 11, 2021 Mar 31, 2021
10-Q Report | Data 10-Q Nov 10, 2020 Sep 30, 2020
10-Q Report | Data 10-Q Aug 14, 2020 Jun 30, 2020
10-Q Report | Data 10-Q May 13, 2020 Mar 31, 2020
10-Q Report | Data 10-Q Nov 7, 2019 Sep 30, 2019
10-Q Report | Data 10-Q Aug 9, 2019 Jun 30, 2019
10-Q Report | Data 10-Q May 9, 2019 Mar 31, 2019
10-Q Report | Data 10-Q Nov 14, 2018 Sep 30, 2018
10-Q Report | Data 10-Q Aug 9, 2018 Jun 30, 2018
10-Q Report | Data 10-Q May 10, 2018 Mar 31, 2018
10-Q Report | Data 10-Q Nov 13, 2017 Sep 30, 2017
10-Q Report | Data 10-Q Aug 10, 2017 Jun 30, 2017
10-Q Report | Data 10-Q May 12, 2017 Mar 31, 2017
10-Q Report | Data 10-Q Nov 14, 2016 Sep 30, 2016
10-Q/A Report | Data 10-Q/A Sep 22, 2016 Jun 30, 2016
10-Q Report 10-Q Aug 25, 2016 Jun 30, 2016